v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Telehealth revenue, net $ 50,162,956 $ 50,887,899
Cost of telehealth revenue 5,925,499 8,136,462
Gross profit 44,237,457 42,751,437
Expenses    
Selling and marketing expenses 29,874,860 22,272,924
General and administrative expenses 15,176,355 14,340,151
Other operating expenses 3,179,946 2,389,536
Customer service expenses 3,139,305 3,071,494
Development costs 1,796,063 1,859,049
Total expenses 53,166,529 43,933,154
Operating loss from continuing operations (8,929,072) (1,181,717)
Interest income (expense), net 56,476 (463,638)
Loss from continuing operations before income taxes (8,872,596) (1,645,355)
Income tax provision
Net loss from continuing operations (8,872,596) (1,645,355)
Net income from discontinued operations 1,993,422
Net (loss) income (8,872,596) 348,067
Net income attributable to non-controlling interest of discontinued operations 531,845
Net loss attributable to LifeMD, Inc. (8,872,596) (183,778)
Preferred stock dividends (776,563) (776,563)
Net loss attributable to LifeMD, Inc. common stockholders $ (9,649,159) $ (960,341)
Basic (loss) earnings per share attributable to LifeMD, Inc. common stockholders:    
Continuing operations $ (0.20) $ (0.06)
Discontinued operations 0.03
Basic loss per share (0.20) (0.02)
Diluted (loss) earnings per share attributable to LifeMD, Inc. common stockholders:    
Continuing operations (0.20) (0.06)
Discontinued operations 0.03
Diluted loss per share $ (0.20) $ (0.02)
Weighted average number of common shares outstanding:    
Basic 47,336,060 43,135,778
Diluted 47,336,060 43,135,778